Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 April 2025 | Story Onthatile Tikoe | Photo Onthatile Tikoe
Zane Dippenaar
Dr Zané Dippenaar (30) is the youngest PhD graduate in this year’s Business Management class from the University of the Free State.

Zané Dippenaar, a 30-year-old marketing and project manager at a Cape Town-based solar energy company, is the youngest person in this year’s graduating class to earn a Doctor of Philosophy (PhD) in Business Management degree from the University of the Free State this year.  

But despite this achievement, the newly minted Dr Dippenaar says she would not have predicted she would study her way to PhD level. 

“I wasn’t particularly academically driven before tertiary education, but I knew from early on that I wanted to either become a teacher or pursue something in the world of business,” she says. Her natural ability and her family’s encouragement led her to explore entrepreneurship and marketing, which she soon developed a passion for.

 

Overcoming challenges and finding support

Dr Dippenaar’s academic journey was marked by significant challenges, including balancing work and study commitments. However, she credits her supervisors and family for helping her stay motivated. 

Her dissertation, titled ‘Advertising and Brand Loyalty in the South African Solar Industry’, showcases her expertise in marketing and branding.

“There were moments filled with doubt, setbacks, and exhaustion, but I was fortunate to have a strong support system who continuously encouraged me and reminded me of what I was working towards,” she says.

 

Achieving a personal milestone

Dr Dippenaar’s PhD achievement is not only an academic milestone but also a personal triumph. She had set a goal of completing her PhD before turning 30 and achieved it just weeks before her birthday. “That was a personal milestone I had set for myself, and achieving it was incredibly fulfilling,” she says. 

She plans to apply the knowledge she gained in the industry and potentially return to academia. She advises younger students to trust their instincts and start their academic journey without waiting for perfection.

“Don’t wait until you’re ‘ready’ – you never will be. Just start. Surround yourself with people who believe in you, ask for help when you need it, and take it one chapter at a time,” she advises.

 

A role model for others

Dr Dippenaar hopes to inspire others, particularly young women, by showing that success in academia doesn’t follow a one-size-fits-all formula. “I hope my story demonstrates that with the right support, determination, and a willingness to carve your own path, anything is possible.”

The University of the Free State is proud to have played a role in Dippenaar’s academic journey, fostering her growth and expertise in business management. Her achievement is a testament to the institution’s commitment to academic excellence and innovation.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept